Panagene Inc - Asset Resilience Ratio

Latest as of September 2025: 0.14%

Panagene Inc (046210) has an Asset Resilience Ratio of 0.14% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 046210 total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets

₩146.73 Million

≈ $99.44K USD Cash + Short-term Investments

Total Assets

₩101.91 Billion

≈ $69.07 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2005–2024)

This chart shows how Panagene Inc's Asset Resilience Ratio has changed over time. See Panagene Inc (046210) net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Panagene Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 046210 market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩146.73 Million	0.14%
Total Liquid Assets	₩146.73 Million	0.14%

Asset Resilience Insights

Limited Liquidity: Panagene Inc maintains only 0.14% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Panagene Inc Industry Peers by Asset Resilience Ratio

Compare Panagene Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Pluristem TA:PSTI	Biotechnology & Medical Research	48.26%
Hadasit Bio TA:HDST	Biotechnology & Medical Research	57.00%
Purple Biotech Ltd TA:KTOV	Biotechnology & Medical Research	0.01%
Peptron Inc KQ:087010	Biotechnology & Medical Research	57.41%
MEDIPOST Co. Ltd KQ:078160	Biotechnology & Medical Research	0.72%
Bioneer Corporation KQ:064550	Biotechnology & Medical Research	14.92%
Macrogen Inc KQ:038290	Biotechnology & Medical Research	3.56%
Cell Biotech Co. Ltd KQ:049960	Biotechnology & Medical Research	54.84%

Annual Asset Resilience Ratio for Panagene Inc (2005–2024)

The table below shows the annual Asset Resilience Ratio data for Panagene Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	55.59%	₩60.93 Billion ≈ $41.29 Million	₩109.61 Billion ≈ $74.28 Million	-28.94pp
2023-12-31	84.53%	₩76.85 Billion ≈ $52.08 Million	₩90.91 Billion ≈ $61.61 Million	+27.00pp
2022-12-31	57.53%	₩19.95 Billion ≈ $13.52 Million	₩34.67 Billion ≈ $23.50 Million	+2.34pp
2021-12-31	55.19%	₩17.61 Billion ≈ $11.93 Million	₩31.91 Billion ≈ $21.62 Million	+11.26pp
2020-12-31	43.93%	₩11.96 Billion ≈ $8.11 Million	₩27.23 Billion ≈ $18.45 Million	+15.76pp
2019-12-31	28.17%	₩6.14 Billion ≈ $4.16 Million	₩21.79 Billion ≈ $14.76 Million	-7.36pp
2018-12-31	35.53%	₩8.55 Billion ≈ $5.80 Million	₩24.08 Billion ≈ $16.32 Million	+2.84pp
2017-12-31	32.69%	₩9.12 Billion ≈ $6.18 Million	₩27.90 Billion ≈ $18.90 Million	-0.24pp
2016-12-31	32.93%	₩10.87 Billion ≈ $7.37 Million	₩33.02 Billion ≈ $22.38 Million	+24.70pp
2012-12-31	8.23%	₩2.10 Billion ≈ $1.42 Million	₩25.51 Billion ≈ $17.28 Million	+2.58pp
2011-12-31	5.66%	₩2.40 Billion ≈ $1.63 Million	₩42.42 Billion ≈ $28.75 Million	+3.02pp
2010-12-31	2.64%	₩1.01 Billion ≈ $684.46K	₩38.31 Billion ≈ $25.96 Million	-0.34pp
2009-12-31	2.98%	₩979.25 Million ≈ $663.62K	₩32.90 Billion ≈ $22.29 Million	-3.35pp
2008-12-31	6.33%	₩3.18 Billion ≈ $2.16 Million	₩50.28 Billion ≈ $34.07 Million	+1.99pp
2007-12-31	4.34%	₩2.20 Billion ≈ $1.49 Million	₩50.68 Billion ≈ $34.35 Million	+3.13pp
2006-12-31	1.21%	₩708.56 Million ≈ $480.18K	₩58.67 Billion ≈ $39.76 Million	+0.86pp
2005-12-31	0.34%	₩218.47 Million ≈ $148.05K	₩63.42 Billion ≈ $42.98 Million	--

pp = percentage points

About Panagene Inc

KQ:046210 Korea Biotechnology & Medical Research

Market Cap

$46.28 Million

₩68.29 Billion KRW

Market Cap Rank

#22171 Global

#1484 in Korea

Share Price

₩2125.00

Change (1 day)

+0.47%

52-Week Range

₩1547.00 - ₩2650.00

All Time High

₩12000.00